The European Commission (EC) has approved a new Opdivo (nivolumab) formulation associated with a new route of administration ...

osimertinib. The PALOMA 3 study was part of a patient-centered program to reduce administration time, exploring the subcutaneous administration route of amivantamab to improve the toxicity profile.

Princeton: Bristol Myers Squibb has received approval from the European Commission (EC) for a new Opdivo (nivolumab) ...

VK2735 Presses On With Dual Routes Of Administration As I noted above, the company is pressing on with both the oral and subcutaneous versions of VK2735 for the treatment of patients with obesity.

“However, given the inconvenience of intravenous route of administration of infliximab, a subcutaneous formulation could significantly increase convenience for patients with autoimmune ...

The development of inhibitors at 2 different dose levels suggests a potential correlation with the subcutaneous route of administration. This unexpected outcome highlights the complexities ...

RANI READ THE FULL RANI RESEARCH REPORT On May 13th Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) reported first quarter 2025 results. Year to date, Rani has updated investors on ProGen’s PG102 asset ...

The results demonstrated that the intradermal dose-saving vaccination route is preferable to the subcutaneous route and that patients in the loCD4 group may require at least one booster to ...

The subcutaneous formulation has the same active ingredient as Vyvgart but a different route of administration. Argenx created the candidate by co-formulating efgartigimod with Halozyme’s ...